Legend Biotech Corporation

LEGN· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$21.11-2.40%

2026-11-02

Financials

Valuation Metrics

Legend Biotech Corporation's Market Cap is $3.92B. At end of 2025 it was $4.02B. Ranked #1500 of 3,118 in US market (top 48%), #518 of 1,474 on NASDAQ (top 35%), #84 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 32%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$3.92B	US#1,500/3,118 Sec#84/265
Revenue	$1.27B	US#1,727/3,118 Sec#46/265
Net Income	$-92M	US—/3,118 Sec—/265
Total Assets	$1.75B	US#2,165/3,118 Sec#59/265
Net Assets	$1.23B	US#1,624/3,118 Sec#54/265
Value
P/B	3.19x	US#1,869/3,118 Sec#104/265
P/S	3.08x	US#1,795/3,118 Sec#56/265
FCF Yield	-6.52%	US—/3,118 Sec—/265
Profitability
ROE	-7.45%	US#2,313/3,118 Sec#75/265
ROA	-5.23%	US#2,523/3,118 Sec#88/265
Op. Margin	-4.42%	US#2,436/3,118 Sec#81/265
Revenue Growth	59.54%	US#177/3,118 Sec#42/265
Financial Health
Debt Ratio	42.40%	US#482/3,118 Sec#131/265
Total Debt	$278M	US#2,118/3,118 Sec#83/265
FCF	$-256M	US#2,823/3,118 Sec#229/265
Cash	$673M	US#894/3,118 Sec#43/265
Current Ratio	3.04x	US#763/3,118 Sec#188/265
Performance
1Y Return	-34.85%	US#2,641/3,118 Sec#212/265
1M Return	13.68%	US#886/3,118 Sec#55/265
From 52W High	-43.71%	US#2,410/3,118 Sec#172/265
1Y MDD	-53.14%	US#2,509/3,118 Sec#178/265
Trading
Volume	988,792 shares	US#890/3,118 Sec#78/265
Trading Value	$21M	US#1,346/3,118 Sec#85/265
Per Share
EPS	$-0.49	US—/3,118 Sec—/265
BPS	$6.62	US#2,125/3,118 Sec#105/265